EP4438114A3 — Methods of making bempedoic acid and compositions of the same
Assigned to Esperion Therapeutics Inc · Expires 2024-12-25 · 1y expired
What this patent protects
The invention provides methods of preparing 8-hy droxy-2,2, 14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hy droxy-2,2, 14, 14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceu…
USPTO Abstract
The invention provides methods of preparing 8-hy droxy-2,2, 14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hy droxy-2,2, 14, 14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceutical materials including a purified amount of 8- hydroxy-2,2, 14, 14-tetramethylpentade-canedioic acid as well as methods of treating various diseases and conditions using the compositions and pharmaceutical materials.
Drugs covered by this patent
- Nexletol (BEMPEDOIC ACID) · Esperion Theraps Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.